Skip to content

13F-HR/A filed by FARALLON CAPITAL MANAGEMENT, L.L.C.

FARALLON CAPITAL MANAGEMENT, L.L.C. filed this 13F-HR/A for the quarter ended 2021-03-31, filed 2021-08-13, with 4 holding rows worth $1,244,497,000.

Accession
0000950123-21-010859
Filed
2021-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, amendment of type new holdings, 4 entries on the cover page, a total value of $1,244,497,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,244,497,000 with VALUE read as thousands by filing date, 13F file number 028-03896. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALEXION PHARMACEUTICALS INC015351109COM5,775,000$883,055,000thousands by filing date
SLACK TECHNOLOGIES INC83088V102COM CL A7,227,300$293,645,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM350,000$53,666,000thousands by filing date
EXTENDED STAY AMER INC30224P200UNIT 99/99/9999B715,499$14,131,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-006783 base2021-05-17acceptance time not in the bulk data set
13F-HR/A 0000950123-21-010859this filing2021-08-13acceptance time not in the bulk data set
13F-HR/A 0000950123-21-015169 added2021-11-15acceptance time not in the bulk data set
13F-HR/A 0001567619-22-003970 added2022-02-14acceptance time not in the bulk data set
13F-HR/A 0001567619-22-010746 added2022-05-16acceptance time not in the bulk data set
13F-HR/A 0001567619-22-011254 added2022-05-19acceptance time not in the bulk data set
13F-HR/A 0001567619-22-015957 added2022-08-15acceptance time not in the bulk data set